Instrument Business Outlook Volume 33 - Issue 14

4 Nov 2024
Table of Contents
  • Survey Raises Concerns About 2025 Capex Budgets
    • Overall Budgets
    • Capex Budgets
    • Delayed/Canceled Purchases
    • Delayed/Canceled Purchases and 2025
  • Executive Briefing
    • Bio-Rad Adds to its Microfluidic Technologies
    • CAMECA Makes Acquisition
    • Bruker Wins Legal Victory in 10x Case
    • Rigaku Completes IPO
    • Calibre Buys Two More Companies and Gains New Funding
    • BioEcho Sold
    • Kewaunee Buys Nu Aire
    • iPSC Product Company Acquired
    • Instrument Service Provider Acquired
  • IBO Stock Indexes Impacted by Last Minute Uncertainty
    • Laboratory Instruments and Products Stock Index
    • Diversified Instrumentation Stock Index
    • International Stocks
  • Market Profile: TOF-ICP-MS
    • Leading Vendors
    • Largest Markets
    • Instrument Cost
  • Industry Watch
    • Clinical: Oncologists Weigh In on CGTs
    • BioPharma: New Type of Cell Therapy Promises Benefits
    • Chemicals: Hazardous Ingredients Found in Personal Care Products
  • Region Watch
    • UK: New R&D Budget Released
    • France: R&D Survives Drastic Budget Cuts
    • EU: Chemical Classification Update
  • News
    • Broad-Based Companies
      • Company Announcements
      • Product Introduction
    • MS & LC-MS
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
    • Sequencing
      • Company Announcements
      • Product Introductions
    • Chromatography
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
  • Bottom Line
Attachments
  • IBO 110424 Issue.pdf